1. Home
  2. SCPH vs KNOP Comparison

SCPH vs KNOP Comparison

Compare SCPH & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • KNOP
  • Stock Information
  • Founded
  • SCPH 2013
  • KNOP 2013
  • Country
  • SCPH United States
  • KNOP United Kingdom
  • Employees
  • SCPH N/A
  • KNOP N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • KNOP Marine Transportation
  • Sector
  • SCPH Health Care
  • KNOP Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • KNOP Nasdaq
  • Market Cap
  • SCPH 173.6M
  • KNOP 199.5M
  • IPO Year
  • SCPH 2017
  • KNOP 2013
  • Fundamental
  • Price
  • SCPH $2.78
  • KNOP $6.67
  • Analyst Decision
  • SCPH Strong Buy
  • KNOP
  • Analyst Count
  • SCPH 3
  • KNOP 0
  • Target Price
  • SCPH $14.00
  • KNOP N/A
  • AVG Volume (30 Days)
  • SCPH 629.3K
  • KNOP 68.9K
  • Earning Date
  • SCPH 03-19-2025
  • KNOP 03-19-2025
  • Dividend Yield
  • SCPH N/A
  • KNOP 1.57%
  • EPS Growth
  • SCPH N/A
  • KNOP N/A
  • EPS
  • SCPH N/A
  • KNOP 0.40
  • Revenue
  • SCPH $36,332,000.00
  • KNOP $312,629,000.00
  • Revenue This Year
  • SCPH $134.20
  • KNOP $1.40
  • Revenue Next Year
  • SCPH $99.40
  • KNOP $2.53
  • P/E Ratio
  • SCPH N/A
  • KNOP $16.84
  • Revenue Growth
  • SCPH 167.28
  • KNOP 8.60
  • 52 Week Low
  • SCPH $2.72
  • KNOP $4.94
  • 52 Week High
  • SCPH $5.65
  • KNOP $9.11
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 34.45
  • KNOP 71.40
  • Support Level
  • SCPH $2.87
  • KNOP $5.35
  • Resistance Level
  • SCPH $3.08
  • KNOP $6.84
  • Average True Range (ATR)
  • SCPH 0.18
  • KNOP 0.22
  • MACD
  • SCPH -0.00
  • KNOP 0.13
  • Stochastic Oscillator
  • SCPH 11.70
  • KNOP 88.59

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests

KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.

Share on Social Networks: